We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SCOTUS Deals Teva Crucial Blow In Drawn-Out Copaxone Patent Battle
SCOTUS Deals Teva Crucial Blow In Drawn-Out Copaxone Patent Battle
The Supreme Court Nov. 13 dealt generic giant Teva a major blow as it denied the company’s request to stay a lower court’s ruling that will allow generic versions of the drugmaker’s blockbuster brand drug Copaxone to hit pharmacy shelves in May.